Skip to the main content.

Data Solutions
In Silico Discovery
Technology
Insight Hub
- Overview
- Blog
- eBook
- Webinars
- Discover NLP
Company
- Overview
- Careers
- News
- Events
- Contact us
Blog

Search

Search

Data Solutions
In Silico Discovery
Technology
Insight Hub
- Overview
- Blog
- eBook
- Webinars
- Discover NLP
Company
- Overview
- Careers
- News
- Events
- Contact us
Blog

Powering
Biotherapeutic
Intelligence™

Insight Hub

Overview
Blog
eBooks
Webinars
Discover NLP

See our latest blog to Blog Listing

to Blog Listing

Contact us to Contact Page

to Contact Page

Powering
Biotherapeutic
Intelligence™

Company

Overview
Careers
Contact

News & Events

In the News
Conferences & Events

See our latest blog to Blog Listing

to Blog Listing

Contact us to Contact Page

to Contact Page

Powering biotherapeutic intelligence

Stories from the leading edge

Blogs

All topics

All
Omics analysis
AI
ML
Precision medicine
Bioinformatics
Drug discovery
NLP
BioStrand Company
R&D
Company culture
Employee spotlight
In silico
Life sciences data management
Antibody discovery
Microbiome
Protein structure prediction
Big data
Biomarker
Cloud computing
Biobank
Biomarkers
Metadata

Insights into genetics and genomics research, and their leading role in the rapid development of the field.

Featured

Computational biology and drug discovery: what to expect in 2023

Computational biology and drug discovery: what to expect in 2023

The year 2022 in computational biology was largely marked by two main advancements:

Most recent

alt=

Creating a unified data + information architecture for scalable AI

alt=

From FAIR Principles to Holistic Data Management in Life Sciences

alt=

Employee Spotlight with Julie Delanote

alt=

On DNA Day, an ode to genomics

alt=

The Importance of Reproducibility in In-Silico Drug Discovery

alt=

Streamlining In Silico Drug Discovery with Cloud Computing

alt=

Targeting Disease with Precision: A Primer on Antibody Discovery

alt=

Protein structure prediction: On the route from sequence to function

alt=

Scaling up structural biology with AlphaFold2

alt=

Data-Driven Biomedical Research

alt=

Exploring the microbiome's impact on immunotherapy efficacy

alt=

Exploring the microbiome-immune axis

alt=

Making Sense of Multi-Omics Data

alt=

Employee Spotlight with Kevin Renaers

alt=

LENSai™ - biotherapeutic intelligence for precision drug development

alt=

Creating an AI-ready data foundation for successful AI-enabled drug discovery

alt=

Employee Spotlight with Simon Cuppens

alt=

Computational biology and drug discovery: what to expect in 2023

alt=

Our most widely read blogs from 2022

alt=

Notes from BioTechX 2022

alt=

Why we love multi-omics analysis

alt=

Employee Spotlight with Carlo Wouters

alt=

Key elements of successful AI-native drug discovery

alt=

What is a biomarker?

alt=

Precision drugs for the precision medicine era

alt=

Employee Spotlight with Tom Vieijra

alt=

What is precision medicine?

alt=

The role of NGS in breast cancer diagnosis and treatment

alt=

Explained: how to plot the prediction quality metrics with AlphaFold2

alt=

BioStrand MedTech Entrepreneurship Story at TU Delft

alt=

A brief retrospective on our second blogiversary

alt=

AI in Biopharma: Challenges and Opportunities

alt=

Quality Control of RNA-seq Data

alt=

Accelerate Biomarker Discovery with Artificial Intelligence

alt=

Top 4 challenges of equitable precision medicine

alt=

Closing the Gap of Text and the Biosphere with LENSai™

alt=

Explained: A brief look into AlphaFold 2

alt=

AI-powered genomics to advance precision medicine

alt=

AI, NLP and the ROI of drug development

alt=

Accelerating pharma R&D and innovation through technology partnerships

alt=

The BioStrand Interviews: Meet Illia Panin

alt=

Improving Drug Safety with Adverse Event Detection Using NLP

alt=

A Hybrid Approach to NLP in Drug Discovery

alt=

Artificial Intelligence in early phase drug development

alt=

The BioStrand Interviews: Meet Yegor Korovin

alt=

Efficient data integration is the key to effective AI/ML

alt=

Attention Mechanisms, Transformers and NLP

alt=

Data related challenges in NLP

alt=

The BioStrand Interviews: Meet Thijs van Ulden

alt=

Knowledge Graphs & The Power Of Context

alt=

AI, ML, DL, and NLP: An Overview

alt=

Why Is NLP Challenging?

alt=

AI in drug development - toward fully autonomous drug discovery

alt=

AI in drug development - from hype to reality

alt=

The importance of NLP in biomedical research

alt=

Accelerating R&D and innovation in life sciences

alt=

The BioStrand Interviews: Meet Georgios Triantopoulos

alt=

The challenges of cloud-first omics

alt=

Challenges In Multi-Omics Data Integration

alt=

The transformative power of text in multi-omics analysis

alt=

AI/ML, Big Data, and Intelligent Bioinformatics

alt=

The BioStrand Interviews: Meet Sébastien Lemal

alt=

The evolution of bioinformatics

alt=

FAIRify your data: A guiding principle

alt=

Bring Meaning to the Chaotic Space of Omics & Text

alt=

Defining next-generation biobanks

alt=

The metadata challenge in biological research

alt=

Learnings from the global response to the pandemic

alt=

The future of precision medicine

alt=

Integrated microbiome research and crop resilience

alt=

Deciphering the skin microbiome

alt=

Key challenges of single-cell data analysis

alt=

Multidimensional scalability in multi-omics research

alt=

Multi-omics data in biomarker discovery

alt=

Bioinformatics and Microbiome Innovations

alt=

Intelligent Multi-Omics Analysis: the Power of AI/ML

alt=

Build vs. Buy: 7 Pros and Cons to Consider

alt=

Integrated Multi-Omics Analysis: From Data Normalisation to Biological Insight

alt=

The SaaSification of Bioinformatics

alt=

The Imperative for Bioinformatics-as-a-Service

alt=

Democratising Omics Data Analysis with Citizen Data Scientists

alt=

BioStrand - Accelerating towards precision

alt=

Data science challenges in population genomics

alt=

Making all omics data computable

alt=

Can Genetics Research Really Be as Simple as a Google Search?

alt=

The advantage of agnostic technology in bioinformatics: general solutions for specific problems

alt=

Harnessing the power of sequence information to enable the next breakthroughs in biology

alt=

The problem of fast and reliable sequence similarity searching

alt=

Multi-domain analysis: why having multi-omics layers under a single hood matters?

alt=

Omics data analysis and precision medicine

alt=

How companies can reduce costs and gain revenue by improving efficiency in R&D

alt=

Which industries gain most by improving genomic sequence analysis

alt=

How exact matching improves accuracy and efficiency in genomic sequence analysis and speeds up research

alt=

The benefits of having DNA, RNA, and protein analysis in a single tool

alt=

The implications of the Covid-19 crisis on infectious disease analysis

alt=

Why Omics Data Analysis Needs To Be Remade

See More

Popular

Explained: how to plot the prediction quality metrics with AlphaFold2 icon blue arrow

Explained: A brief look into AlphaFold 2 icon blue arrow

AI, ML, DL, and NLP: An Overview icon blue arrow

Artificial Intelligence in early phase drug development icon blue arrow

Creating an AI-ready data foundation for successful AI-enabled drug discovery icon blue arrow

Knowledge Graphs & The Power Of Context icon blue arrow

Back to Insight Hub

Let’s accelerate change. Partner with us.

Subscribe to our blog:

Technology
- Overview
In Silico Discovery
- Overview
Data Management
- Overview

Insight Hub
- Overview
- Blog
- eBooks
- Webinars
- Discover NLP

Company
- Overview
- News
- Events
- Careers

Connect
- Contact us
- IPA corporate site

Follow Us
Twitter
LinkedIn
YouTube
Medium

Sign-up for latest news, blogs and more

BioStrand is an independently operating subsidiary of IPA

Privacy
Legal Notice
Cookie Policy

© 2023 BioStrand BV. All rights reserved. BioStrand BV is an independently operating subsidiary of ImmunoPrecise Antibodies Ltd. BioStrand is a trademark of BioStrand BV.